Pharmagenesis, Inc.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Pharmagenesis, Inc..The latest application filed is for "polygalacturonan rhamnogalacturonan1 (pgrg1) composition".

Company Profile

1.22.7

Pharmagenesis, Inc. - Redwood City CA US
Pharmagenesis, Inc. -
Pharmagenesis, Inc. - Palo Alto CA
PHARMAGENESIS, INC. - 3183 Porter Drive, Palo Alto CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks

Patent Activity

Patent	Date
Polygalacturonan Rhamnogalacturonan1 (PGRG1) Composition App 20170232035 - MUSSER; John H ; et al.	2017-08-17
Intravenous Formulations Of Triptolide Compounds As Immunomodulators And Anticancer Agents App 20160038454 - AN; Jinhua ; et al.	2016-02-11
Identification and screening of triptolide target molecules Grant 8,617,906 - Fidler , et al. December 31, 2	2013-12-31
Identification and screening of triptolide target molecules Grant 08617906 -	2013-12-31
Triptolide lactone ring derivatives as immunomodulators and anticancer agents Grant 8,426,616 - Yuan , et al. April 23, 2	2013-04-23
Triptolide C-ring derivatives as anticancer agents and immune modulators Grant 8,268,882 - Musser September 18, 2	2012-09-18
Triptolide C-ring Derivatives As Anticancer Agents And Immune Modulators App 20110288166 - Musser; John H.	2011-11-24
Methods for isolation of triptolide compounds from Tripterygium wilfordii Grant 8,048,914 - An , et al. November 1, 2	2011-11-01
Triptolide lactone ring derivatives as immunomodulators and anticancer agents Grant 7,863,464 - Yuan , et al. January 4, 2	2011-01-04
Triptolide derivatives for modulation of apoptosis and immunosuppression Grant 7,847,109 - Dai , et al. December 7, 2	2010-12-07
Triptolide 5,6-derivatives as immunomodulators and anticancer agents Grant 7,820,834 - Dai , et al. October 26, 2	2010-10-26
Triptolide derivatives for modulation of apoptosis and immunosuppression Grant 7,662,976 - Dai , et al. February 16, 2	2010-02-16
Halogenated triptolide derivatives as immunomodulators and anticancer agents Grant 7,417,069 - Dai , et al. August 26, 2	2008-08-26
Identification and Screening Of Triptolide Target Molecules App 20080193948 - Fidler; John M. ; et al.	2008-08-14
Method for Treatment of Inflammatory Disorders Using Triptolide Compounds App 20070244080 - Fidler; John M. ; et al.	2007-10-18
Triptolide derivatives as immunomodulators and anticancer agents Grant 7,098,348 - Dai , et al. August 29, 2	2006-08-29
Triptolide derivatives as immunomodulators and anticancer agents Grant 7,019,151 - Dai , et al. March 28, 2	2006-03-28
Acid-modified arabinogalactan protein composition Grant 6,991,817 - An , et al. January 31, 2	2006-01-31
Halogenated triptolide derivatives as immunomodulators and anticancer agents App 20050288364 - Dai, Dongcheng ; et al.	2005-12-29
Halogenated triptolide derivatives as immunomodulators and anticancer agents Grant 6,943,259 - Dai , et al. September 13, 2	2005-09-13
Uses of diterpenoid triepoxides as an anti-proliferative agent Grant 6,599,499 - Rosen , et al. July 29, 2	2003-07-29
Triptolide prodrugs having high aqueous solubility Grant 6,548,537 - Dai , et al. April 15, 2	2003-04-15
Triptolide prodrugs having high aqueous solubility Grant 6,150,539 - Musser November 21, 2	2000-11-21
Immunosuppressive compounds and methods Grant 5,962,516 - Qi , et al. October 5, 1	1999-10-05
Immunotherapy composition and method Grant 5,843,452 - Wiedmann , et al. December 1, 1	1998-12-01
Method for suppressing xenograft rejection Grant 5,759,550 - Wiedmann , et al. June 2, 1	1998-06-02
Immunosuppressive compounds and methods Grant 5,663,335 - Qi , et al. September 2, 1	1997-09-02
Immunosuppressant diterpene compound Grant 5,648,376 - Strobel , et al. July 15, 1	1997-07-15
Tripterinin compound and method Grant 5,468,772 - Xu , et al. November 21, 1	1995-11-21

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.